How big is the inhalation anesthesia industry?

The global inhalation anesthesia market size was valued at USD 1.91 billion in 2023 and is predicted to reach USD 3.61 billion by 2034. Read More

What is the growth rate of inhalation anesthesia market?

The global inhalation anesthesia market is expected to growing at a noteworthy CAGR of 5.97% over forecast period 2024 to 2034. Read More

Which factors driving the inhalation anesthesia market growth?

Growing numbers of surgical procedures across the globe, along with emergence of the trauma cases worldwide are some among the major factors driving growth of the global market. Additionally, increasing geriatric population, increasing cancer patient pool, rising cardiovascular, gastrointestinal, respiratory, neurological disorders are expected to propel growth of the target market in next 10 years. Read More

Which segment accounted for the largest inhalation anesthesia market share?

Anesthetics product type segment is expected to account for the major share in the target market. The growth is attributed to growing adoption of the anesthetics in the various end use applications worldwide. Read More

Who are the key companies operating in the inhalation anesthesia market?

The main firms working in the global inhalation anesthesia industry across the globe Piramal Critical Care, Baxter, Midmark Corporation, Halocarbon, Hengrui Medicine, Kent Scientific Corporation, Merck KGaA, BOC, AbbVie Inc. Raman & Weil Pvt. Ltd. Read More

Which region is probable to list the remarkable CAGR in inhalation anesthesia market?

Asia Pacific is probable to list the remarkable CAGR, on account of growing demand for the inhalation anesthesia in end use industry. Read More

Inhalation Anesthesia Market Size, Share, and Trends 2024 to 2034

The global inhalation anesthesia market size was USD 1.91 billion in 2023, calculated at USD 2.02 billion in 2024 and is projected to surpass around USD 3.61 billion by 2034, expanding at a CAGR of 5.97% from 2024 to 2034.

Last Updated : September 2024
Report Code : 1247
Category : Healthcare

Inhalation Anesthesia Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Inhalation Anesthesia Market

5.1. COVID-19 Landscape: Inhalation Anesthesia Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Inhalation Anesthesia Market, By Product Type

8.1. Inhalation Anesthesia Market Revenue and Volume, by Product Type, 2024-2034

8.1.1 Apparatus

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Anesthetics

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Accessories

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Inhalation Anesthesia Market, By Application

9.1. Inhalation Anesthesia Market Revenue and Volume, by Application, 2024-2034

9.1.1. Human Healthcare

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Veterinary Healthcare

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Inhalation Anesthesia Market, By End user

10.1. Inhalation Anesthesia Market Revenue and Volume, by End user, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Ambulatory Surgical Centres

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Inhalation Anesthesia Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)

Chapter 12. Company Profiles

12.1. Piramal Critical Care

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Baxter

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Midmark Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Halocarbon

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hengrui Medicine

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Kent Scientific Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Merck KGaA

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. BOC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. AbbVie Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Raman & Weil Pvt. Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

We use cookies to improve your experience

Inhalation Anesthesia Market Size To Hit USD 3.61 Bn By 2034

List of Contents